4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000028
Chief Scientific Officer acquired 6,775,068 shares (other)
From the SEC's structured data for this filing
Trades in this filing
NIGALAYE ASHOK G · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-03-25 | Other acquisition : show line 1 in the form | +6,775,068 | $0.04 | $250,000 | 15,060,666 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2013-03-25 | Other acquisition : show line 2 in the form Warrants | +6,666,667 | 2,436,665 | I |
Loading xslF345X03/primary_doc.xml…